StockRing: 11/15/09, (NASDAQ:GENZ), $49.28, "SELL-SHORT" Genzyme Corporati (GENZ) Stock on Sunday, November 15, 2009

Login    About Us    Our Blog    Our Twitter    Contact Us     11/15/09, (NASDAQ:GENZ), $49.28, "SELL-SHORT" Genzyme Corporati (GENZ) Stock  GENZ opened at $53.06 and it is $-3.89, (-7.32%). Today's trading range is $47.80 - 53.99. 1y target price is $59.78.  DOW     +0.72%    +73.00    10270.47           ENGLAND     +0.38%    +19.88    5296.38           JAPAN     -0.35%    -34.18    9770.31  NASDAQ     +0.88%    +18.86    2167.88           GERMANY     +0.40%    +22.87    5686.83           CHINA     +0.46%    +14.7    3187.647  S&P 500     +0.57%    +6.24    1093.48           FRANCE     -0.05%    -2.06    3806.01           INDIA     +0.92%    +152.8    16848.83  CANADA     +0.41%    +46.92    11407.68           ITALY     -1.09%    -174.00    15743.00           RUSSIA     -0.41%    -5.85    1419.49  MEXICO     +0.79%    +242.24    31002.090           SWISS     -0.07%    -4.68    6351.08           TAIWAN     -0.07%    -5.3    7665.63

Stocks Funds SYMBOL:    YouTube Our Blog 11/11/09 StockRing Urgent Advice: Buy stocks on 11/12/09 - expect gains this week !!!    Option Exp: SAMPLE ! Option Exp:    EUROs for $1 DOLLAR: 3 MONTHS       Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!! 1. Dow Jones Index - 30 Stocks on 11/12/2009:  Buy   93% or 28   Hold   7% or 2   Sell   0% or 0 stocks     2. World Markets - 72 Indexes on 11/11/2009:  Buy   63% or 44   Hold   21% or 15   Sell   16% or 11 indexes 3. Best Brands - 200 stocks on 11/12/2009:  Buy   76% or 152   Hold   17% or 33   Sell   7% or 14 stocks 4. Hot News - 200 stocks on 11/8/2009:  Buy   47% or 93   Hold   23% or 46   Sell   30% or 60 stocks 5. Big Movers - 200 stocks on 11/14/2009:  Buy   69% or 137   Hold   23% or 47   Sell   8% or 15 stocks 6. Top Hitters - 200 stocks on 11/11/2009:  Buy   77% or 153   Hold   15% or 31   Sell   8% or 15 stocks 7. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 9. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 10. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 11. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 12. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 13. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 14. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 15. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 16. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 17. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks                                              TOTAL RATINGS:   Buy   60% or 2493   Hold   27% or 1080   Sell   13% or 517 stocks Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings 11/15/2009  Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "SELL-SHORT"for Genzyme Corporati (NASDAQ:GENZ) Stock. GENZ stock opening price was $53.06 per share. Current price of NASDAQ:GENZ Stock is $49.28 per share and it is $-3.89, (-7.32%) today and it was trading in the daily range of $47.80 - 53.99 per share. Current Bid Price for (NASDAQ:GENZ) stock is $49.05 and the Ask Price is $49.39. In the last 52 weeks GENZ stock was trading in the range of $47.09 - 73.75. 50-Day Moving Average for (NASDAQ:GENZ) stock is $54.0505 and 200-Day Moving Average is $55.1408. On average analysts predict that One Year Target Estimated price for (NASDAQ:GENZ) stock is $59.78. Genzyme Corporati (NASDAQ:GENZ) Market capitalization is $13.078B. (NASDAQ:GENZ) stock average daily volume is 3,329,350 shares per day. However, on last trading session of Nov 13, 2009 GENZ stock traded 27,982,142 shares. Also The Short Ratio for (NASDAQ:GENZ) stock is 1.40. On previous trading session GENZ Stock closed at $53.17 per share. Last year Genzyme Corporati (NASDAQ:GENZ) before taxes (EBITDA) (ttm) earned $1.631B on total revenue of $4.608B. Earnings Per Share - EPS (ttm) for GENZ stock is 1.754. Also, (NASDAQ:GENZ) Stock Price Per Earnings ratio - P/E is 30.31. Thus, (NASDAQ:GENZ) Stock Price/Sales (ttm) ratio is 3.06 and Price/Book (mrq) ratio is 1.85. (NASDAQ:GENZ) Stock does NOT PAY any dividend. So at this time (NASDAQ:GENZ) Stock maintains Trailing Annual Dividend Rate at 0.00 . StockRing Recommendations for Genzyme Corporati (NASDAQ:GENZ) Stock are updated daily here http://www.StockRing.com/sr/StockDetail.asp?StockName=GENZ If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com. GENZ Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 11/15/2009 1 Year Stock market price chart for Genzyme Corporati (NASDAQ:GENZ) Stock on Sunday, November 15, 2009    1 Year Dow Jones Chart 1 Year S&P 500 Chart 1 Year Nasdaq Chart 1 Year Canada Chart 11/15/2009 5 days Stock market price chart for Genzyme Corporati (NASDAQ:GENZ) Stock on Sunday, November 15, 2009    5 Days Dow Jones Chart 5 Days S&P 500 Chart 5 Days Nasdaq Chart 5 Days Canada Chart GENZ Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 11/15/2009 Stock market price quote data for Genzyme Corporati (NASDAQ:GENZ) Stock on Sunday, November 15, 2009 Last Trade: 49.28 Trade Time: Nov 13 Change: -3.89, (-7.32%) Prev Close: 53.17 Open: 53.06 Bid: 49.05 Ask: 49.39 1y Target Est: $59.78 50-Day Moving Average: 54.0505 200-Day Moving Average: 55.1408 Short Ratio: 1.40 Trailing Annual Dividend Rate: 0.00 Day's Range: 47.80 - 53.99 52wk Range: 47.09 - 73.75 Volume: 27,982,142 Avg Vol: 3,329,350 Market Cap: 13.078B P/E (ttm): 30.31 EPS (ttm): 1.754 Div & Yield: 0.00 (N/A%) Revenue (ttm): 4.608B Earnings before Tax (EBITDA) (ttm): 1.631B Price/Sales (ttm): 3.06 Price/Book (mrq): 1.85 Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!    EUROs for $1 DOLLAR: 3 MONTHS       Genzyme Corporation (NasdaqGS: GENZ) Company Information Genzyme Corp. 500 Kendall Street Cambridge, MA 02142 United States - Map Phone: 617-252-7500 Fax: 617-252-7600 Web Site: http://www.genzyme.com Genzyme Corporation (NasdaqGS: GENZ) DETAILS Genzyme Corporation (NasdaqGS: GENZ) Index Membership: S&P 500 S&P 1500 Super Comp Nasdaq 100 Genzyme Corporation (NasdaqGS: GENZ) Sector: Healthcare Genzyme Corporation (NasdaqGS: GENZ) Industry: Biotechnology Genzyme Corporation (NasdaqGS: GENZ) Full Time Employees: 11,000 Genzyme Corporation (NasdaqGS: GENZ) BUSINESS SUMMARY Genzyme Corporation operates as a biotechnology company worldwide. The company?s Genetic Diseases segment manufactures and distributes therapeutic products, including Cerezyme as an enzyme replacement therapy for the treatment of Type 1 and Type 3 Gaucher diseases; Fabrazyme, a recombinant form of the human enzyme alpha- galactosidase for the treatment of Fabry disease; Myozyme as a therapy for Pompe disease; and Aldurazyme for the treatment of Mucopolysaccharidosis I. This segment markets and sells its products directly to physicians, hospitals, treatment centers, pharmacies, and government agencies through distributors. Its Cardiometabolic and Renal segment develops, manufactures, and distributes products consisting of Renagel and Renvela for the control of serum phosphorus in patients with chronic kidney disease on dialysis; Hectorol, a line of vitamin D2 pro-hormone products for the treatment of secondary hyperparathyroidism; and Thyrogen, an adjunctive diagnostic agent used in the follow-up of patients with well-differentiated thyroid cancer. This segment sells its products to retail pharmacies, hospitals, and other providers of medication to patients. The company?s Biosurgery segment provides biotherapeutics and biomaterial-based products, which comprise Synvisc, a biomaterial-based product that is used to treat the pain associated with osteoarthritis of the knee; and Sepra family of products to prevent adhesions following various surgical procedures in the abdomen and pelvis. Its Hematologic Oncology segment develops products for the treatment of cancer, which include Campath for the treatment of B-cell chronic lymphocytic leukemia; Clolar for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia; and Mozobil for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma. The company was founded in 1981 and is based in Cambridge, Massachusetts. Genzyme Corporation (NasdaqGS: GENZ) KEY EXECUTIVES, SALARIES and BONUSES Mr. Henri A. Termeer , Age: 62 Exec. Chairman, Chief Exec. Officer and Pres Salary: $ 3.54M Bonus: $ 0 Mr. Michael S. Wyzga , Age: 53 Chief Financial Officer and Exec. VP of Fin. Salary: $ 999.00K Bonus: $ 1.36M Mr. Sandford D. Smith , Age: 61 Pres of International Group Salary: $ 979.00K Bonus: $ 711.00K Mr. Earl M. Collier Jr., Age: 61 Exec. VP Salary: $ 1.05M Bonus: $ 3.54M Mr. Peter Wirth Esq., Age: 58 Exec. VP of Corp. Devel., Exec. VP of Legal and Sec. Salary: $ 1.22M Bonus: $ 0 1. Dow Jones Index - 30 Stocks on 11/12/2009:  Buy   93% or 28   Hold   7% or 2   Sell   0% or 0 stocks     2. World Markets - 72 Indexes on 11/11/2009:  Buy   63% or 44   Hold   21% or 15   Sell   16% or 11 indexes 3. Best Brands - 200 stocks on 11/12/2009:  Buy   76% or 152   Hold   17% or 33   Sell   7% or 14 stocks 4. Hot News - 200 stocks on 11/8/2009:  Buy   47% or 93   Hold   23% or 46   Sell   30% or 60 stocks 5. Big Movers - 200 stocks on 11/14/2009:  Buy   69% or 137   Hold   23% or 47   Sell   8% or 15 stocks 6. Top Hitters - 200 stocks on 11/11/2009:  Buy   77% or 153   Hold   15% or 31   Sell   8% or 15 stocks 7. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 9. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 10. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 11. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 12. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 13. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 14. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 15. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 16. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 17. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks                                              TOTAL RATINGS:   Buy   60% or 2493   Hold   27% or 1080   Sell   13% or 517 stocks 11/15/2009 Latest stock market news data for Genzyme Corporati (NASDAQ:GENZ) Stock on Sunday, November 15, 2009 Market Winners & Losers: Abercrombie & Fitch, Genzyme FOXBusiness - Nov 14, 2009 By David O'Brien The major indexes closed the week on a winning note, making up most of Thursday's losses. The Dow closed up 0.7%, the S&P 500 added 0.6% and the Nasdaq gained 0.9%. The teen ... Business Highlights istockAnalyst.com - Nov 14, 2009 (Source: Associated Press/AP Online) Weak dollar no quick fix for narrowing trade gap WASHINGTON (AP) - A weaker dollar may boost the nation's economy by increasing exports and narrowing the trade ... JC Penney, Disney, Genzyme are big movers The Associated Press - Nov 13, 2009 NEW YORK — The following stocks were among those that moved substantially or traded heavily Friday on the New York Stock Exchange: NYSE: JC Penney Co., up $1.82 at $31.21 The department ... JC Penney, Disney, Genzyme, Petsmart, Agilent are among big market movers Friday - Gaea Times Genzyme Corporation Issues Letters to U.S. Healthcare Providers Reuters Key Development - Nov 13, 2009 Closing Bell: What Friday 13th curse? (ANF, BA, GENZ, DIS, PALM, PLA) BloggingStocks - Nov 13, 2009 This was one of those low-volume trading days where more stocks were up than down with the big explanation being "fewer sellers than buyers." Commodity import prices, the trade deficit, and a weak ... Midday Unusual Options Activity Update - TRA, SHPGY, GENZ, PALM, QLGC, DIS, JCP, AGO, JWN, ANF, AMX The Options Insider - Nov 13, 2009 Terra Industries (TRA) implied volatility is moving higher amid activity call buying Friday. Shares are up $1.02 to $36.22 and 11,900 call options had traded by midday, which represents 2.5X the ... US FDA Says Some Genzyme Corporation's Drugs Contaminated-Reuters Reuters Key Development - Nov 13, 2009 Trash in drugs sends Genzyme lower FXstreet.com The Forex Market - Nov 13, 2009 by Andrew Wilkinson GENZ- Genzyme Corp. – A hot topic in the last few minutes has seen shares of biotech company, Genzyme slide by 5% to $50.50 with the AP reporting that the FDA has found tiny ... Table of Unusual NASDAQ Stock Moves From Townsend Analytics Wall Street Journal - Nov 13, 2009 HOTTREND LIST OF MOST ABNORMALLY TRADED STOCKS DATE: 11/13/2009 COUNTRY: US EXCHANGE: NASDAQ TIME PREIOD: 9:30 - 3:30 LAST CHANGE %CHANGE RANK COMPANY NAME TICKER PRICE ON DAY ON DAY 1 NETLIST INC ... Shire Pharmaceuticals (SHPGY) calls active as shares rally StreetInsider.com - Nov 13, 2009 Shire Pharmaceuticals (Nasdaq: SHPGY), a specialty pharmaceutical company, is recently up $2.42 to $58.97 as Genzyme (Nasdaq: GENZ) sells ... StreetInsider.com provides up-to-the-minute active ... MiamiHerald.com More contamination troubles for Genzyme Boston Globe Shares of Genzyme yesterday plunged 7.3 percent, a loss of $3.89, to $49.28 on the Nasdaq stock exchange, their biggest drop since February, as investors ... FDA Warns Doctors of Contamination at Genzyme (GENZ) Plant; Stock TumblesStreetInsider.com (subscription) Foreign Particles Found In Genzyme MedicinesWall Street Journal The FDA Find Bits Of Trash In Genzyme DrugsRedOrbit Bloomberg -TheStreet.com -MSN Money all 355 news articles » RTT News Genzyme Q3 net income plummets amid plant shutdown woes Mass High Tech Genzyme's (Nasdaq: GENZ) stock was trading at $53.50 a share in morning trading Wednesday, down from $54.85 a share at the previous day's close. REFILE-ANALYSIS-Genzyme virus exposes vulnerable plant processesReuters Genzyme Q3 Profit Falls 87%; Cuts FY09 Earnings OutlookRTT News Genzyme Reports Third-Quarter Financial ResultsBusiness Wire (press release) all 145 news articles » Table of Unusual NASDAQ Stock Moves From Townsend Analytics Wall Street Journal Each stock has a constantly updated profile based on measures like price change, volume, money flow and others. A stock becomes "abnormal" when it deviates ... and more » NASDAQ:GENZ, ISIS, OSIP - Top Biotech Stocks - Stock Alert TransWorldNews (press release) Genzyme Corporation (NASDAQ:GENZ) surges 2.16% or $1.11 to $52.54 on a massive volume of 2.14 million shares after yesterday it lowered its fiscal 2009 ... and more » About this author: Seeking Alpha (blog) Genzyme (GENZ) is seeing 9X average trading volume, with 73000 contracts traded and call volume representing 51 percent of today's trading activity. ... By: Zacks Equity Research Zacks.com Revenues in the reported quarter included the recognition of $10 million in revenue under the company's agreement with Genzyme Corporation (GENZ - Analyst ... and more » Stocks erase gains in final hour as Bove cuts Wells Fargo San Diego Daily Transcript (subscription) (Nasdaq: GENZ) declined 6.2 percent to $51.43. The world's largest maker of drugs for rare genetic disorders reported third-quarter profit excluding some ... and more » By: Zacks Equity Research Zacks.com Collaboration partner Genzyme (GENZ - Analyst Report) intends to file the first new drug application (NDA) for mipomersen in the US for homozygous familial ... and more » BTG 1H Pretax Profit Down 25%; Eyeing Drug Buys Wall Street Journal (GENZ) is testing leukemia medicine Campath in multiple sclerosis patients, while AstraZeneca PLC (AZN.LN) is due to start a Phase II trial of sepsis ... and more » Stocks rise to extend market's second straight weekly gain San Diego Daily Transcript (subscription) (Nasdaq: GENZ) dropped 7.3 percent to $49.28 for the biggest decline in the S&P 500. US regulators said some lots of the company's Cerezyme, Fabrazyme, ... and more » 11/15/2009 News from StockRing Blog about Genzyme Corporati (NASDAQ:GENZ) Stock on Sunday, November 15, 2009 12/7/2008 StockRing advise: SELL 33% or 163, HOLD 47% or 237, BUY ... GENZ, HOLD - Genzyme Corporation (NasdaqNM : GENZ), Dec 5, 65.53, +4.32, +7.06%, 3697165. 195. GILD, HOLD - Gilead Sciences, Inc. (NasdaqNM : GILD), Dec 5, 47.39, +1.84, +4.04%, 11575311. 196. GIS, HOLD - General Mills, Inc. ... 12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ... genz, hold - genzyme corporation (nasdaqnm : genz), dec 5, 65.53, +4.32, +7.06%, 3697165. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), dec 5, 47.39, +1.84, +4.04%, 11575311. 196. gis, hold - general mills, inc. (nyse : gis ... 12/25/2008 stockring advise: sell 35% or 176, hold 39% or 195, buy ... genz, hold - genzyme corporation (nasdaqnm : genz), dec 24, 66.22, -0.18, -0.27%, 577885. 195. gild, buy - gilead sciences, inc. (nasdaqnm : gild), dec 24, 50.46, +0.46, +0.92%, 3002901. 196. gis, super sell - general mills, ... 11/22/2008 stockring buy-sell-hold ratings for s&p 500 stocks genz, hold - genzyme corporation (nasdaqnm : genz), nov 20, 66.87, -1.13, -1.66%, 4594444. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), nov 20, 41.53, -1.67, -3.87%, 10959634. 196. gis, hold - general mills, ... 12/3/2008 stockring advise: sell 39.4% or 197, hold 50.4% or 252 ... genz, super sell - genzyme corporation (nasdaqnm : genz), 4:00pm, 63.56, +3.52, +5.86%, 4167883. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), 4:00pm, 46.17, +2.08, +4.72%, 11310658. 196. gis, super sell - general mills, ... 12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ... genz, hold - genzyme corporation (nasdaqnm : genz), dec 5, 65.53, +4.32, +7.06%, 3697165. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), dec 5, 47.39, +1.84, +4.04%, 11575311. 196. gis, hold - general mills, inc. (nyse : gis ... 12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ... genz, hold - genzyme corporation (nasdaqnm : genz), dec 5, 65.53, +4.32, +7.06%, 3697165. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), dec 5, 47.39, +1.84, +4.04%, 11575311. 196. gis, hold - general mills, inc. (nyse : gis ... 12/3/2008 stockring advise: sell 39.4% or 197, hold 50.4% or 252 ... genz, super sell - genzyme corporation (nasdaqnm : genz), dec 3, 63.56, +3.52, +5.86%, 4167883. 195. gild, hold - gilead sciences, inc. (nasdaqnm : gild), dec 3, 46.17, +2.08, +4.72%, 11310658. 196. gis, super sell - general mills, ...    Abele John   Abrams George    Abrams Jonathan   Ackermann Josef   ACUSHNET   A.I.G.   AIG   Albright Madeleine   AMAZON.COM   AMERITRADE   Andelman David   Andreessen Marc   Angwin Julia   Anthony Jim   APAX PARTNERS   ARCH VENTURE PARTNERS   ARONSSON GROUP   Ashworth Paul   AT&T   AVON BOOKS   Bair Sheila   BANK OF AMERICA   BARCLAYS   Barton Rich   Bassett Angela   BEAR STEARNS   Begich Mark   Bell Bryon   Bennett Tony   Berke Barry   Bernanke Ben   BET   BETSEY JOHNSON   Biaggi Mario   Bierut Michael   Biondi Frank   Blankfein Lloyd   Blinder Alan   Bock Jeff   BOEING   Boncompagni Tatiana   Bond Adam   Bond Victoria   Born Brooksley   BOSTON SCIENTIFIC   BP   Brazinski Daniel   Breslin Jimmy   Brody Kenneth   Brown Greg   Burkle Ron   Burow Kristina   Burrough Bryan   Bush George W.   Callan Erin   CALLAWAY GOLF   CARLYLE GROUP    CASCADE INVESTMENT   Cassano Joseph   Dauman Philippe   De Niro Robert   Dickerson Paul   Dillon Harrison   DISNEY   Dodd Christopher   Donaldson William   Douglas Michael   Draghi Mario   DREAMWORKS SKG   DUTTON   Dykstra Lenny   Eisner Michael   ELECTRONIC ARTS   Emanuel Rahm   ENRON   ESL INVESTMENTS   Evans Robert   Falcone Philip   FANNIE MAE   FEDERATED DEPARTMENT   STORES   FINANCO   Flavin Jennifer   Fleckenstein Bill   Foreman George   Frank Barney   Frears Stephen   FREDDIE MAC   Freston Tom   Friedman Stephen   Fuld Dick   Furman Roy   Garavani Valentino   Gates Bill   Geffen David   Geithner Tim   GENERAL MOTORS   Gensler Gary   Gerdeman Fred   Gibson Charles   GLASSDOOR   GLG PARTNERS   GOLDMAN SACHS   Greenspan Alan   Greenspan Glenn   Grey Brad   Griffin Kathy   Griffin Ken   Grove Andy   HALSTON   HARBINGER CAPITAL   PARTNERS   Harrison Gilbert   Harrison Mya   HCR MANORCARE   HEWLETT-PACKARD   HILCO CONSUMER   CAPITAL   Hohman Robert   JEFFRIES & CO.   Jobs Steve   Johnson Magic   Johnson Robert   Jolie Angelina   Jordan Michael   JP MORGAN CHASE   Kaczynski Ted   Karan Donna   Kargman Jill   Karmazin Mel   Kashkari Neel   King Larry   Knowles Beyonce   KohlbergJerry   KopelmanArie   KopelsonAnne   KopelsonArnold   Korff Ira   Korff Kimberlee   Kurzman David   Lagrange Pierre   Lampert Eddie   Lansing Sherry   LEHMAN BROTHERS   LENDINGTREE   Levitt Arthur   Levy Leon   Liddy Ed   LINKEDIN   Little Edward   Loeb Allan   Lois George   LONG-TERM CAPITAL   MANAGEMENT   Lonski John   Lundgren Terry   MACYS   Madoff Bernie   Marcus Bernie   Marriott Bill   Maskin Eric   Mason Richard   MATTHEW WILLIAMSON   MAY DEPARTMENT   STORES   McCombs Red   McKinnon Mark   McLucas William   Meltzer Allan   MERRILL LYNCH   MGM   MICROSOFT   MIDWAY GAMES   Misner Jeff   Mitchell Andrea   Moglia Joe   Molinaro Sam   MOODYS INVESTORS   SERVICE   Moonves Leslie   Morgan Peter   MORGAN STANLEY   Moses Herb   MOTOROLA   Mozilo Angelo   Murdoch Rupert   Murphy Eddie   MYSPACE   Nader Ralph   Nardelli Bob   NATIONAL AMUSEMENTS   NEWS CORP.   Nicholas Pete   Nicklaus Tack   NICKLAUS DESIGN   NIKE   Norquist Grover   NRDC EQUITY PARTNERS   Obama Barack   ODYSSEY PARTNERS   Oman Brady   OPPENHEIMER & CO.   OReilly Bill   OReilly Tim   OVERTURE FILMS   Paese Michael   Palin Sarah   PALM   Pandit Vikram   PARAMOUNT PICTURES   Partnoy Frank   Pataki George   Paulson Henry   Paulson John   Preston Kelly   Purcell Philip   Pyle Jason   RBS GREENWICH CAPITAL   Reardon Roy   Redstone Brent   Redstone Eddie   Redstone Michael   Redstone Paula   Redstone Phyllis   Redstone Shari   Redstone Sumner   RELIANCE   RENAISSANCE TECHNOLOGIES   ROYAL DUTCH SHELL   Rubin Robert   SAC CAPITAL ADVISORS   SALTON   SAPPHIRE ENERGY   Schiff Stephen   Schrager Ian   Schumer Chuck   Schwartz Alan   Scott Lee   Shields Brooke   SHUTTERFLY   SIEMENS   Silverman Ben   Simons James   SIX APART   SOCIALIZR   SOLAZYME   Sorkin Aaron   Sorkin Andrew Ross   Soros George   Spielberg Steven   Spurlock Morgan   Stallone Sylvester   Stanley Stephen   Staubach Roger   Steel Robert   Steinberg Mark   Stern Andy   Stiglitz Joseph   ST. MARTINS PRESS   Stone Oliver   Sullivan Mark T.   Summers Lawrence   SUTTER HILL VENTURES   TACONIC CAPITAL PARTNERS   DESIGN TOMMY HILFIGER   Travolta John   Trump Ivanka   TSM CAPITAL   CENTURY FOX   AFRIKA   TYCO   UBS   UNITED ARTISTS   UNIVERSAL   VALENTINO FASHION   GROUP   VANTAGE   V AUSTRALIA   VENROCK ASSOCIATES   VIA COM   Volcker Paul   VONAGE   WACHOVIA   Wagner Paula   Wales Jimmy   Wallison Peter   WAL-MART   WarinJoseph   WARNER BROTHERS   WASHINGTON MUTUAL   Waters Maxine   Waxman Henry   Weinstein Bob   Weinstein Harvey   WEINSTEIN CO.   Weiser Stanley   Welch Jack   Welling Beau   Whitacre Ed   White Kevin   Whitehead John   Williams Brian   Wilson Victoria   WMS INDUSTRIES   Wolfson Jonathan    Copyright © 2009 StockRing.com. All rights reserved. Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.

Buy from S&P 500:
Akamai - AKAM
Amazon.com - AMZN
Big Lots - BIG


Sell from S&P 500:
Alcoa - AA
Autodesk - ADSK
Aflac - AFL


Buy from S&P 400 MidCap:
Carmax - KMX
99c Stores - NDN
Netflix - NFLX


Sell from S&P 400 MidCap:
Timken - TKR
Trinity - TRN
Aflac - AFL


Buy from S&P 600 SmallCap:
Coinstar - CSTR
Holly - HOC
Maximus - MMS


Sell from S&P 600 SmallCap:
Barnes - B
Cascade - CAE
Brightpoint - CELL


Buy from Nasdaq 100:
Baidu.com - BIDU
Verisign - VRSN
Yahoo - YHOO


Sell from Nasdaq 100:
Adobe - ADBE
Amgen - AMGN
Costco - COST


Buy from Nasdaq Telecom:
Adtran - ADTN
CalAmp - CAMP
KongZhong - KONG


Sell from Nasdaq Telecom:
iBasis - IBAS
Interphase - INPH
RCN Corp - RCNI


Buy from Nasdaq Biotech:
Eurand - EURX
Illumina - ILMN
Trimeris - TRMS


Sell from Nasdaq Biotech:
Antigenics - AGEN
Celera - CRA
Incyte - INCY


Buy from Nasdaq Computer:
eLoyalty - ELOY
LogicVision - LGVN
Macrovision - MVSN


Sell from Nasdaq Computer:
Amtech - ASYS
Bsquare - BSQR
Corel - CREL


Buy from Nasdaq Finance:
Elbit - EMITF
Chardan - CACA
Tree.com - TREE


Sell from Nasdaq Finance:
BancFirst - BANF
FirstMerit - FMER
Advanta - ADVNA